Deanna May
Family · Greensboro, NCNPI 1093271546
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Lilly USA, LLC accounts for 76.9% of it on its own, with 37 other manufacturers making up the rest. Among family clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 556 payments — averaging $108.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$47K
- Eli Lilly$4K
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Johnson & Johnson$1K
- Bristol Myers Squibb$763
- plus $4K from 32 others
What the payments were for
- Consulting fees$7,05012%
- Speaking & faculty fees$33,37555%
- Travel & lodging$7,90713%
- Food & beverage$12,08220%
- Education$1300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$60,544 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 25 | $38,840 |
| ZenpepLipase/Protease/Amylase | 11 | $32,480 |
| LinzessLinaclotide | 21 | $21,487 |
| Dexlansoprazole DrDexlansoprazole | 25 | $11,232 |
| Lubiprostone | 12 | $3,752 |
| Desipramine Hcl | 40 | $2,898 |
| Dicyclomine Hcl | 61 | $998 |
| Pantoprazole Sodium | 61 | $991 |
| Lansoprazole | 28 | $574 |
| Ondansetron OdtOndansetron | 17 | $523 |
| Doxepin Hcl | 12 | $404 |
| Omeprazole | 32 | $383 |
| Esomeprazole Magnesium | 12 | $333 |
| Ondansetron Hcl | 13 | $219 |
| Amitriptyline Hcl | 11 | $144 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $2,341 | $60,32646 claims |
| Aimmune Therapeutics, Inc.Zenpep | $17 | $32,48011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,522 family providers in North Carolina.
Other family in Greensboro
- Christine DaleGreensboro$12K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.